Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 3284 entries
View as:

Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01350921 Org: User:
Start: 05/31/11 End: 03/31/12 Due: 03/31/13

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Phase: N/A Priority: Normal
NCT ID: NCT04159519 Org: User:
Start: 07/27/20 End: 01/31/23 Due: 01/31/24

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00099320 Org: User:
Start: 05/31/04 End: 08/31/05 Due: 08/31/06

A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687

Phase: N/A Priority: Normal
NCT ID: NCT01046357 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

T790M Mutation Positive 2nd Line STandard of cAre Registry

Phase: N/A Priority: Normal
NCT ID: NCT02368990 Org: User:
Start: 06/30/15 End: 06/30/18 Due: 06/30/19

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Phase: N/A Priority: Normal
NCT ID: NCT05943106 Org: User:
Start: 08/11/23 End: 05/30/27 Due: 05/30/28

Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03272165 Org: User:
Start: 10/17/17 End: 03/31/21 Due: 03/31/22

Children, Perennial Allergic Rhinitis (PAR), l-t Growth

Phase: N/A Priority: Normal
NCT ID: NCT00641212 Org: User:
Start: 01/31/00 End: 04/30/03 Due: 04/30/04

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Phase: N/A Priority: Normal
NCT ID: NCT00502385 Org: User:
Start: 04/30/04 End: - Due: -

eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services

Phase: N/A Priority: Normal
NCT ID: NCT05712096 Org: User:
Start: 03/09/23 End: 05/30/23 Due: 05/30/24

REported Outcomes in COPD With Trixeo in Real worlD

Phase: N/A Priority: Normal
NCT ID: NCT05213611 Org: User:
Start: 08/11/22 End: 07/30/24 Due: 07/30/25

A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT04856007 Org: User:
Start: 04/12/21 End: 06/14/21 Due: 06/14/22

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Phase: N/A Priority: Normal
NCT ID: NCT06422689 Org: User:
Start: 05/10/24 End: 04/29/26 Due: 04/29/27

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03298451 Org: User:
Start: 10/11/17 End: 08/27/26 Due: 08/27/27

An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00864929 Org: User:
Start: 11/30/09 End: 10/31/10 Due: 10/31/11

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01031680 Org: User:
Start: 02/28/10 End: 12/31/12 Due: 12/31/13

Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat

Phase: N/A Priority: Normal
NCT ID: NCT05961384 Org: User:
Start: 11/18/21 End: 01/15/22 Due: 01/15/23

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

Phase: N/A Priority: Normal
NCT ID: NCT00659750 Org: User:
Start: 12/31/03 End: 04/30/05 Due: 04/30/06

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

Phase: N/A Priority: Normal
NCT ID: NCT00206284 Org: User:
Start: 05/31/04 End: 04/30/05 Due: 04/30/06

Tezepelumab COPD Exacerbation Study

Phase: N/A Priority: Normal
NCT ID: NCT04039113 Org: User:
Start: 07/30/19 End: 01/31/24 Due: 01/31/25

Physician Survey on Monitoring of Patients Treated With Quetiapine

Phase: N/A Priority: Normal
NCT ID: NCT01795326 Org: User:
Start: 06/30/13 End: 09/30/13 Due: 09/30/14

A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04492709 Org: User:
Start: 07/30/20 End: 10/19/20 Due: 10/19/21

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02046850 Org: User:
Start: 02/28/14 End: 04/30/14 Due: 04/30/15

AZD5438 in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00088790 Org: User:
Start: 07/31/04 End: 12/31/05 Due: 12/31/06

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Phase: N/A Priority: Normal
NCT ID: NCT00225589 Org: User:
Start: 08/31/02 End: 05/31/06 Due: 05/31/07